Kymriah Data Shows Sustained Remission In Kids, Young Adults
Novartis’ Kymriah created history five years ago when it became the first gene therapy to be licenced in the United States. As Novartis has attempted...
FDA Officials Support Moderna, Pfizer COVID-19 Jabs For Kids
Parents may soon be allowed to line up their children for vaccinations after Pfizer and Moderna's COVID-19 vaccine application for young children progresses through...
FDA Not So Fast On Approval Of The Novavax COVID-19 Vaccine
The US handed Novavax a $1.6 billion funding 4 months into the pandemic, in July 2020, to speed the biotech's research of a coronavirus...
FDA Rebukes Althera On Cholesterol Medication Assertions
Althera Pharmaceuticals, a producer of cardiovascular drugs, is being investigated by the FDA for its cholesterol oral delivery medicine, Roszet. The FDA's Office of...
Seqirus, North Carolina Gets Fill Finish Expansion of $156mn
Seqirus recently completed a $156 million expansion plan at its Holly Springs, North Carolina, fill-finish production plant, which began in 2018. The expanded facility,...
GARDP Helps Bugworks Assess New Antibiotics Effectiveness
The Global Antibiotic Research and Development Partnership- GARDP and Bugworks are working together on research to determine the safety profile of a novel class of broad-spectrum...
GSK Unveils Its Transformation Through New Branding And Logo
The British Big Pharma has launched an innovative rebranding, a tech-flavoured logo, and an impactful transformation for the future as GlaxoSmithKline turns GSK and...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...